157 related articles for article (PubMed ID: 28544443)
1. Development of a clinical trials version of the Impact of Weight on Quality of Life-Lite questionnaire (IWQOL-Lite Clinical Trials Version): results from two qualitative studies.
Kolotkin RL; Ervin CM; Meincke HH; Højbjerre L; Fehnel SE
Clin Obes; 2017 Oct; 7(5):290-299. PubMed ID: 28544443
[TBL] [Abstract][Full Text] [Related]
2. Validation of a new measure of quality of life in obesity trials: Impact of Weight on Quality of Life-Lite Clinical Trials Version.
Kolotkin RL; Williams VSL; Ervin CM; Williams N; Meincke HH; Qin S; von Huth Smith L; Fehnel SE
Clin Obes; 2019 Jun; 9(3):e12310. PubMed ID: 30993900
[TBL] [Abstract][Full Text] [Related]
3. Psychometric evaluation of the impact of weight on quality of life-lite questionnaire (IWQOL-lite) in a community sample.
Kolotkin RL; Crosby RD
Qual Life Res; 2002 Mar; 11(2):157-71. PubMed ID: 12018739
[TBL] [Abstract][Full Text] [Related]
4. Confirmatory psychometric evaluations of the Impact of Weight on Quality of Life-Lite Clinical Trials Version (IWQOL-Lite-CT).
Kolotkin RL; Williams VSL; von Huth Smith L; Meincke HH; Qin S; Williams N; Fehnel SE
Clin Obes; 2021 Oct; 11(5):e12477. PubMed ID: 34296522
[TBL] [Abstract][Full Text] [Related]
5. Development of a brief measure to assess quality of life in obesity.
Kolotkin RL; Crosby RD; Kosloski KD; Williams GR
Obes Res; 2001 Feb; 9(2):102-11. PubMed ID: 11316344
[TBL] [Abstract][Full Text] [Related]
6. Psychometric evaluation of a Brazilian version of the impact of weight on quality of life (IWQOL-Lite) instrument.
de A Mariano MH; Kolotkin RL; Petribú K; de N L Ferreira M; Dutra RF; Barros MV; Almeida NC; de L Filho LE; Rabelo PJ; Monteiro V; da Silva BF
Eur Eat Disord Rev; 2010 Jan; 18(1):58-66. PubMed ID: 20054878
[TBL] [Abstract][Full Text] [Related]
7. Performance of a weight-related measure of Quality of Life in a psychiatric sample.
Kolotkin RL; Crosby RD; Corey-Lisle PK; Li H; Swanson JM
Qual Life Res; 2006 May; 15(4):587-96. PubMed ID: 16688492
[TBL] [Abstract][Full Text] [Related]
8. Psychometric evaluation of the German version of the impact of weight on Quality of Life-Lite (IWQOL-Lite) questionnaire.
Mueller A; Holzapfel C; Hauner H; Crosby RD; Engel SG; Mühlhans B; Kolotkin RL; Mitchell JE; Horbach T; Zwaan Md
Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):69-74. PubMed ID: 20658439
[TBL] [Abstract][Full Text] [Related]
9. Psychometric evaluation of the IWQOL-Lite (Spanish version) when applied to a sample of obese patients awaiting bariatric surgery.
Andrés A; Saldaña C; Mesa J; Lecube A
Obes Surg; 2012 May; 22(5):802-9. PubMed ID: 21898041
[TBL] [Abstract][Full Text] [Related]
10. The relationship between health-related quality of life and weight loss.
Kolotkin RL; Crosby RD; Williams GR; Hartley GG; Nicol S
Obes Res; 2001 Sep; 9(9):564-71. PubMed ID: 11557837
[TBL] [Abstract][Full Text] [Related]
11. Assessing weight-related quality of life in obese persons with type 2 diabetes.
Kolotkin RL; Crosby RD; Williams GR
Diabetes Res Clin Pract; 2003 Aug; 61(2):125-32. PubMed ID: 12951281
[TBL] [Abstract][Full Text] [Related]
12. Estimating a preference-based single index for the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) instrument from the SF-6D.
Brazier JE; Kolotkin RL; Crosby RD; Williams GR
Value Health; 2004; 7(4):490-8. PubMed ID: 15449641
[TBL] [Abstract][Full Text] [Related]
13. Patient-reported quality of life in a randomized placebo-controlled trial of naltrexone/bupropion for obesity.
Kolotkin RL; Chen S; Klassen P; Gilder K; Greenway FL
Clin Obes; 2015 Oct; 5(5):237-44. PubMed ID: 26222044
[TBL] [Abstract][Full Text] [Related]
14. One-year health-related quality of life outcomes in weight loss trial participants: comparison of three measures.
Kolotkin RL; Norquist JM; Crosby RD; Suryawanshi S; Teixeira PJ; Heymsfield SB; Erondu N; Nguyen AM
Health Qual Life Outcomes; 2009 Jun; 7():53. PubMed ID: 19505338
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: What mediates improvement?
Kolotkin RL; Gadde KM; Peterson CA; Crosby RD
Qual Life Res; 2016 May; 25(5):1237-44. PubMed ID: 26446094
[TBL] [Abstract][Full Text] [Related]
16. Effect of once-weekly subcutaneous semaglutide 2.4 mg on weight- and health-related quality of life in an East Asian population: Patient-reported outcomes from the STEP 6 trial.
Kolotkin RL; Jeppesen OK; Baker-Knight J; Lee SY; Tokita A; Kadowaki T
Clin Obes; 2023 Aug; 13(4):e12589. PubMed ID: 36905345
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of the quality of psychometric evidence supporting the use of an obesity-specific quality of life measure for use with persons who have class III obesity.
Forhan M; Vrkljan B; MacDermid J
Obes Rev; 2010 Mar; 11(3):222-8. PubMed ID: 19493301
[TBL] [Abstract][Full Text] [Related]
18. Content identification of the IWQOL-Lite with the International Classification of Functioning, Disability and Health.
Tessier A; Mayo NE; Cieza A
Qual Life Res; 2011 May; 20(4):467-77. PubMed ID: 21061070
[TBL] [Abstract][Full Text] [Related]
19. Assessing weight-related quality of life in adolescents.
Kolotkin RL; Zeller M; Modi AC; Samsa GP; Quinlan NP; Yanovski JA; Bell SK; Maahs DM; de Serna DG; Roehrig HR
Obesity (Silver Spring); 2006 Mar; 14(3):448-57. PubMed ID: 16648616
[TBL] [Abstract][Full Text] [Related]
20. Effect of semaglutide 2.4 mg on physical functioning and weight- and health-related quality of life in adults with overweight or obesity: Patient-reported outcomes from the STEP 1-4 trials.
Rubino D; Bjorner JB; Rathor N; Sharma AM; von Huth Smith L; Wharton S; Wadden T; Zeuthen N; Kolotkin RL
Diabetes Obes Metab; 2024 Jul; 26(7):2945-2955. PubMed ID: 38698650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
